financetom
Business
financetom
/
Business
/
Ryerson Q3 revenue misses estimates, net loss widens as tariffs bite
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ryerson Q3 revenue misses estimates, net loss widens as tariffs bite
Oct 28, 2025 1:50 PM

Overview

* Ryerson ( RYI ) Q3 revenue of $1.16 bln, in-line with analyst expectations

* Company reports Q3 net loss of $14.8 mln, diluted loss per share $0.46

* Adjusted EBITDA of $40.3 mln beats analyst estimates

Outlook

* Ryerson ( RYI ) did not provide specific future financial guidance in its press release

Result Drivers

* SELF-HELP ACTIONS - Co executed self-help actions to achieve revenue within guidance despite weak demand and tariff pricing conditions

* PRICE INCREASE - Average selling prices increased by 2.6% compared to the prior quarter

* DEMAND AND TARIFFS - Weak demand and tariff pricing conditions impacted results

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Meet $1.16 $1.16

Revenue bln bln (2

Analysts

)

Q3 EPS -$0.46

Q3 Net -$14.80

Income mln

Q3 Beat $40.3 $38.80

Adjusted mln mln (2

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the iron & steel peer group is "buy."

* Wall Street's median 12-month price target for Ryerson Holding Corp ( RYI ) is $24.00, about 4.7% above its October 27 closing price of $22.87

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing commercial jet deliveries drop by two in April
Boeing commercial jet deliveries drop by two in April
May 14, 2024
May 14 (Reuters) - Boeing ( BA ) said on Tuesday it delivered 24 commercial airplanes last month, down by two from the 26 planes it handed over to customers during a weak April for deliveries a year ago, as the U.S. planemaker works to improve production of its 737 MAX. Boeing ( BA ) also reported 33 cancellations for...
Battery Future Acquisition Enters Merger Agreement With Class Over
Battery Future Acquisition Enters Merger Agreement With Class Over
May 14, 2024
11:01 AM EDT, 05/14/2024 (MT Newswires) -- Battery Future Acquisition ( BFAC ) has entered into a merger agreement with Class Over that values the educational technology platform at about $135 million, the companies said Tuesday. The deal would provide Class Over gross proceeds of about $56 million at closing and lead to Class Over's expected listing on the New...
What's Going On With Virgin Galactic Stock?
What's Going On With Virgin Galactic Stock?
May 14, 2024
Virgin Galactic Holdings, Inc. ( SPCE ) shares are trading higher Tuesday as a rally in heavily-shorted stocks continues amid the return of Roaring Kitty to social media. The Details: The return of Roaring Kitty to social media has sparked a meme stock revival which began with shares of GameStop and AMC Entertainment and has extended to other stocks with...
Satellos Bioscience Q1 Loss Widens Due To Higher Expenses; But Says
Satellos Bioscience Q1 Loss Widens Due To Higher Expenses; But Says "On track" to initiate Phase 1 First-in-human Clinical Trials Mid-2024
May 14, 2024
11:01 AM EDT, 05/14/2024 (MT Newswires) -- Satellos Bioscience Inc. ( MSCLF ) , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, earlier on Tuesday reported a first-quarter net loss of $6.9 million, or $0.06 per share, wider than a loss $1.7 million, or $0.04 per share, a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved